Cargando…
Improving the therapeutic index in adoptive cell therapy: key factors that impact efficacy
The therapeutic index (TI) is a quantitative assessment of a drug safety proportional to its effectiveness. The estimation is intuitive when the engagement of the product with its target is dependent on stable chemistry and predictable pharmacokinetics as is the case for small molecules or antibodie...
Autores principales: | Wang, Ena, Cesano, Alessandra, Butterfield, Lisa H, Marincola, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539608/ https://www.ncbi.nlm.nih.gov/pubmed/33023983 http://dx.doi.org/10.1136/jitc-2020-001619 |
Ejemplares similares
-
The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
por: Masucci, Giuseppe V., et al.
Publicado: (2017) -
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
por: Markovska, Martina, et al.
Publicado: (2021) -
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010) -
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015) -
Cancer immunotherapy trials: leading a paradigm shift in drug development
por: Emens, Leisha A., et al.
Publicado: (2016)